Cardiff, CA, United States of America

Kevin L Tays




Average Co-Inventor Count = 11.6

ph-index = 4

Forward Citations = 26(Granted Patents)


Location History:

  • Cardiff, CA (US) (2003 - 2010)
  • Cardiff by the Sea, CA (US) (2008 - 2017)

Company Filing History:


Years Active: 2003-2017

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):

Title: The Innovative Contributions of Kevin L Tays

Introduction

Kevin L Tays is a prominent inventor based in Cardiff, California, known for his significant contributions to the field of pharmaceuticals. With a total of 13 patents to his name, Tays has made remarkable advancements in the development of compounds that target various health conditions.

Latest Patents

Among his latest patents are innovative compounds such as diamino-pyridine, pyrimidine, and pyridazine, which serve as H-receptor modulators. These compounds are designed for use in pharmaceutical compositions and methods aimed at treating disease states, disorders, and conditions mediated by H-receptor activity, including allergy, asthma, autoimmune diseases, and pruritis. His work on diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor further exemplifies his commitment to addressing complex health issues through innovative solutions.

Career Highlights

Throughout his career, Tays has worked with notable companies in the pharmaceutical industry, including Ortho-McNeil Pharmaceutical Corporation and Janssen Pharmaceutica NV. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in the field.

Collaborations

Tays has collaborated with esteemed colleagues such as Hui Cai and Steven P Meduna, further enhancing the impact of his work through shared knowledge and expertise.

Conclusion

Kevin L Tays stands out as a dedicated inventor whose work has the potential to transform the treatment of various medical conditions. His innovative patents and collaborations reflect his commitment to advancing pharmaceutical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…